Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements "TREASURE"

Not yet recruiting

Phase 2/3 Results N/A

Summary of Purpose

The primary objectives of this study is to evaluate the efficacy of HLCM051 on functional outcome in subjects with acute ischemic stroke and to evaluate the safety of HLCM051 in subjects with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 November 2016.

1 Jan 2017 7 Nov 2016 1 Mar 2018 Unavailable 1 Nov 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts

Not available